Skip to main content
XXII
NASDAQ Manufacturing

22nd Century Group Faces Going Concern Warning Amid Dilutive Financing and Revenue Decline

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
9
Price
$3.43
Mkt Cap
$1.678M
52W Low
$3.29
52W High
$841.8
52W Position info
4.3% above low
Off High info
100% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

XXII is trading near its 52-week low of $3.29 (4.3% above the low).

Summary

22nd Century Group's annual report reveals substantial doubt about its ability to continue as a going concern, exacerbated by a highly dilutive $16 million Series B preferred stock offering used for refinancing, and continued revenue decline and net losses. However, the company secured new manufacturing and distribution agreements and received a $9.5 million insurance settlement, providing some operational and liquidity improvements amidst its financial distress.


Key Events · Financing and Capital Events · XXII

  • Going Concern Warning & Deeply Dilutive Financing

    Management expressed substantial doubt about the company's ability to continue as a going concern, following an initial $16 million Series B Preferred Stock offering with highly dilutive conversion terms (15% discount to VWAP, $0.714 floor) used primarily for refinancing. This offering was previously announced on March 20, 2026, and finalized on March 24, 2026, with this filing providing execution details and use of proceeds.

  • Continued Financial Underperformance

    Full-year 2025 net revenues declined by 27.9% to $17.587 million, and the company reported a net loss of $5.054 million, alongside a history of multiple reverse stock splits to maintain Nasdaq compliance, including a 1-for-15 split in January 2026.

  • Strategic Operational Wins & Liquidity Boost

    The company secured new master services agreements with Smoker Friendly International and Murphy Oil USA for manufacturing and distribution of tobacco products, including its VLN brand. Additionally, it received a $9.5 million insurance settlement in October 2025 related to a November 2022 facility fire, significantly boosting liquidity.


Analysis · XXII · Manufacturing

This annual report highlights critical financial distress for 22nd Century Group, with management explicitly stating substantial doubt about the company's ability to continue as a going concern. The recently completed $16 million Series B Convertible Preferred Stock offering, while providing capital, is highly dilutive due to its deeply discounted conversion terms (15% discount to VWAP, $0.714 floor) and was primarily used to repurchase existing Series A Preferred Stock rather than funding new growth. This financing structure, coupled with a 27.9% decline in full-year 2025 net revenues and persistent net losses, signals a precarious financial position. The company's history of multiple reverse stock splits, including a 1-for-15 split in January 2026, further underscores its struggles to maintain Nasdaq listing requirements. While new manufacturing and distribution agreements with Smoker Friendly International and Murphy Oil USA, along with a $9.5 million insurance settlement, offer some positive operational developments and a boost to liquidity, they do not fundamentally alleviate the severe financial challenges and the going concern risk.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 42.7% of the 288 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XXII was trading at $3.43 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $3.29 to $841.80. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Sep 28, 2026, 9:15 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.39
Real-time Price: $0.890 info
Change: -$0.4975 (-36%) info
Market Cap: $652.591K info
XXII
Aug 14, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $0.890 info
Change: -$3.44 (-79%) info
Market Cap: $652.591K info
XXII
Aug 14, 2026, 4:13 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $4.33
Real-time Price: $0.890 info
Change: -$3.44 (-79%) info
Market Cap: $652.591K info
XXII
Aug 13, 2026, 6:14 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $0.890 info
Change: -$3.30 (-79%) info
Market Cap: $652.591K info
XXII
Aug 13, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $0.890 info
Change: -$3.30 (-79%) info
Market Cap: $652.591K info